CommoditiesFertilizers & AgrochemicalsPesticides & Agrochemicals

Astec Lifesciences Ltd

Showing the latest 10 filings. Sign in to filter or browse the full history.
10 of 62 filings·Updated 1 Oct 2026
Showing 10 of 62 filings.
1 Oct 20262 filings
Company UpdateClarification

The Exchange has sought clarification from Astec Lifesciences Ltd on October 1, 2026, with reference to Movement in Volume.<BR><BR>The reply is awaited.

No brief for this announcement.This type of announcement aren’t summarised. View the original using the link below
Filed 15:10
Company UpdateSpurt in Volume

Significant increase in volume has been observed in Astec LifeSciences Limited. The Exchange, in order to ensure that investors have latest relevant information about the company and to inform the market place so that the interest of the investors is safeguarded, had written to the company. Astec LifeSciences Limited has submitted their response.

No brief for this announcement.This type of announcement aren’t summarised. View the original using the link below
Filed 10:58View Source
30 Sept 20261 filing
Company UpdateSpurt in Volume

Significant increase in volume has been observed in Astec LifeSciences Limited. The Exchange, in order to ensure that investors have latest relevant information about the company and to inform the market place so that the interest of the investors is safeguarded, has written to the company. The response from the company is awaited.

No brief for this announcement.This type of announcement aren’t summarised. View the original using the link below
Filed 19:33View Source
28 Sept 20261 filing
Insider Trading / SASTClosure of Trading Window

Astec LifeSciences Limited – Trading Window closed from 1st October, 2026 till 48 (forty-eight) hours after the declaration of the Unaudited Financial Results of the Company for the Quarter and Half Year ending on 30th September, 2026

Astec LifeSciences Limited – Trading Window closed from 1st October, 2026 till 48 (forty-eight) hours after the declaration of the Unaudited Financial Results of the Company for the Quarter and Half Year ending on 30th September, 2026

Filed 17:42View Source
18 Sept 20263 filings
Company UpdateGeneral

Astec Lifesciences confirms compliance with listing and PIT regulations; no new disclosures

Regulatory compliance

  • Company confirms ongoing compliance with Listing Regulations and PIT; no developments requiring mandatory disclosure.
Filed 15:35View Source
Company UpdateClarification

The Exchange has sought clarification from Astec Lifesciences Ltd on September 18, 2026, with reference to Movement in Volume.<BR><BR>The reply is awaited.

No brief for this announcement.This type of announcement aren’t summarised. View the original using the link below
Filed 12:18
Company UpdateSpurt in Volume

Significant increase in volume has been observed in Astec LifeSciences Limited. The Exchange, in order to ensure that investors have latest relevant information about the company and to inform the market place so that the interest of the investors is safeguarded, had written to the company. Astec LifeSciences Limited has submitted their response.

No brief for this announcement.This type of announcement aren’t summarised. View the original using the link below
Filed 10:49View Source
17 Sept 20261 filing
Company UpdateSpurt in Volume

Significant increase in volume has been observed in Astec LifeSciences Limited. The Exchange, in order to ensure that investors have latest relevant information about the company and to inform the market place so that the interest of the investors is safeguarded, has written to the company. The response from the company is awaited.

No brief for this announcement.This type of announcement aren’t summarised. View the original using the link below
Filed 17:32View Source
11 Sept 20262 filings
Company UpdateGeneral

Astec LifeSciences confirms compliance; no new mandatory disclosures under Listing Regulations or PIT

Regulatory compliance status

  • Confirming compliance with Listing Regulations Regulation 30 and PIT Regulations.
  • No developments requiring mandatory disclosure as of 11 September 2026.
Filed 10:10View Source
Company UpdatePrice movement

Significant movement in price has been observed in Astec LifeSciences Limited. The Exchange, in order to ensure that investors have latest relevant information about the company and to inform the market place so that the interest of the investors is safeguarded, had written to the company. Astec LifeSciences Limited has submitted their response.

No brief for this announcement.This type of announcement aren’t summarised. View the original using the link below
Filed 09:38View Source
Showing 10 of 62 filings